Fig. 2

EF24 inhibits tumor growth in-vivo. A A brief flowchart of the experiment design in-vivo. A549 xenograft tumor was established and divided into the following four groups and received 17-day treatment: control, EF24 (5 mg/kg/d, 10 mg/kg/d and 20 mg/kg/d). B The weight of tumors. C The curves of tumor growth. D The body weight of mice. E Representative images of xenografts from different groups. F H&E staining tumor tissue sections of different groups. Magnification: 100×. G Anti-Ki-67 staining of tumor tissues in different groups. Magnification: 200×. The results shown are means ± SD; *P < 0.05